Aurelie Meunier - Publications

Cost-Effectiveness and Public Health Impact of Newborn Screening for Spinal Muscular Atrophy in France.

Journal: Applied health economics and health policy

Published: July 25, 2025

An eye on equity: faricimab-driven health equity improvements in diabetic macular oedema using a distributional cost-effectiveness analysis from a UK societal perspective.

Journal: Eye (London, England)

Published: July 13, 2023

Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key Drivers.

Journal: PharmacoEconomics

Published: May 11, 2023

Distributional Cost-Effectiveness Analysis of Health Technologies: Data Requirements and Challenges.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: March 11, 2022

Cost Consequence Analysis of the Management of Hyperkalemia by Patiromer and Optimization of Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Chronic Kidney Disease Patients in Saudi Arabia.

Journal: Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia

Published: February 01, 2022

Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores.

Journal: Applied health economics and health policy

Published: August 25, 2021

Mapping analysis to predict SF-6D utilities from health outcomes in people with focal epilepsy.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: March 29, 2021

HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: November 07, 2019